137 related articles for article (PubMed ID: 22855847)
21. Patient age and number of apheresis days may predict development of secondary myelodysplastic syndrome and acute myelogenous leukemia after high-dose chemotherapy and autologous stem cell transplantation for lymphoma.
Ge I; Saliba RM; Maadani F; Popat UR; Qazilbash MH; Ravi Pingali S; Shah N; Ahmed S; Bashir Q; Nieto Y; Champlin RE; Hosing C
Transfusion; 2017 Apr; 57(4):1052-1057. PubMed ID: 28185276
[TBL] [Abstract][Full Text] [Related]
22. Secondary neoplasms following treatment for brain tumors.
Weinstein JL; Ayyanar K; Watral MA
Cancer Treat Res; 2009; 150():239-73. PubMed ID: 19834673
[No Abstract] [Full Text] [Related]
23. Characteristics and Outcomes of Second Malignant Neoplasms after Childhood Cancer Treatment: Multi-Center Retrospective Survey.
Koh KN; Yoo KH; Im HJ; Sung KW; Koo HH; Kim HS; Han JW; Yoon JH; Park HJ; Park BK; Baek HJ; Kook H; Lee JA; Lee JM; Lee KC; Kim SK; Park M; Lee YH; Lyu CJ; Seo JJ
J Korean Med Sci; 2016 Aug; 31(8):1254-61. PubMed ID: 27478336
[TBL] [Abstract][Full Text] [Related]
24. Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d'Or (Burgundy, France).
Maynadié M; Girodon F; Manivet-Janoray I; Mounier M; Mugneret F; Bailly F; Favre B; Caillot D; Petrella T; Flesch M; Carli PM
Haematologica; 2011 Jan; 96(1):55-61. PubMed ID: 20971817
[TBL] [Abstract][Full Text] [Related]
25. Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomide.
Rollison DE; Shain KH; Lee JH; Hampras SS; Fulp W; Fisher K; Al Ali NH; Padron E; Lancet J; Xu Q; Olesnyckyj M; Kenvin L; Knight R; Dalton W; List A; Komrokji RS
Cancer Med; 2016 Jul; 5(7):1694-701. PubMed ID: 27098006
[TBL] [Abstract][Full Text] [Related]
26. Risk for the development of treatment-related acute myelocytic leukemia and myelodysplastic syndrome among patients with breast cancer: review of the literature and the National Surgical Adjuvant Breast and Bowel Project experience.
Smith RE
Clin Breast Cancer; 2003 Oct; 4(4):273-9. PubMed ID: 14651772
[TBL] [Abstract][Full Text] [Related]
27. Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials.
Koontz MZ; Horning SJ; Balise R; Greenberg PL; Rosenberg SA; Hoppe RT; Advani RH
J Clin Oncol; 2013 Feb; 31(5):592-8. PubMed ID: 23295809
[TBL] [Abstract][Full Text] [Related]
28. Myelodysplastic Syndromes and Acute Myeloid Leukemia After Radiotherapy for Prostate Cancer: A Population-Based Study.
Wang R; Zeidan AM; Yu JB; Soulos PR; Davidoff AJ; Gore SD; Huntington SF; Gross CP; Ma X
Prostate; 2017 Apr; 77(5):437-445. PubMed ID: 27868212
[TBL] [Abstract][Full Text] [Related]
29. Age related risk of myelodysplastic syndrome and acute myeloid leukemia among breast cancer survivors.
Kaplan HG; Malmgren JA; Li CI; Calip GS
Breast Cancer Res Treat; 2013 Dec; 142(3):629-36. PubMed ID: 24265034
[TBL] [Abstract][Full Text] [Related]
30. Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511).
Freedman RA; Seisler DK; Foster JC; Sloan JA; Lafky JM; Kimmick GG; Hurria A; Cohen HJ; Winer EP; Hudis CA; Partridge AH; Carey LA; Jatoi A; Klepin HD; Citron M; Berry DA; Shulman LN; Buzdar AU; Suman VJ; Muss HB
Breast Cancer Res Treat; 2017 Jan; 161(2):363-373. PubMed ID: 27866278
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study.
Granfeldt Østgård LS; Medeiros BC; Sengeløv H; Nørgaard M; Andersen MK; Dufva IH; Friis LS; Kjeldsen E; Marcher CW; Preiss B; Severinsen M; Nørgaard JM
J Clin Oncol; 2015 Nov; 33(31):3641-9. PubMed ID: 26304885
[TBL] [Abstract][Full Text] [Related]
32. Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study.
Takahashi K; Wang F; Kantarjian H; Doss D; Khanna K; Thompson E; Zhao L; Patel K; Neelapu S; Gumbs C; Bueso-Ramos C; DiNardo CD; Colla S; Ravandi F; Zhang J; Huang X; Wu X; Samaniego F; Garcia-Manero G; Futreal PA
Lancet Oncol; 2017 Jan; 18(1):100-111. PubMed ID: 27923552
[TBL] [Abstract][Full Text] [Related]
33. Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study.
Gillis NK; Ball M; Zhang Q; Ma Z; Zhao Y; Yoder SJ; Balasis ME; Mesa TE; Sallman DA; Lancet JE; Komrokji RS; List AF; McLeod HL; Alsina M; Baz R; Shain KH; Rollison DE; Padron E
Lancet Oncol; 2017 Jan; 18(1):112-121. PubMed ID: 27927582
[TBL] [Abstract][Full Text] [Related]
34. Second malignancies following treatment in non-Hodgkin's lymphoma.
Ellis M; Lishner M
Leuk Lymphoma; 1993 Mar; 9(4-5):337-42. PubMed ID: 8348069
[TBL] [Abstract][Full Text] [Related]
35. Cytogenetics, not just previous therapy, determines the course of therapy-related myeloid neoplasms.
Larson RA
J Clin Oncol; 2012 Jul; 30(19):2300-2. PubMed ID: 22585693
[No Abstract] [Full Text] [Related]
36. Leukemia and other related hematological disorders among Danish patients exposed to Thorotrast.
Andersson M; Carstensen B; Visfeldt J
Radiat Res; 1993 May; 134(2):224-33. PubMed ID: 8488256
[TBL] [Abstract][Full Text] [Related]
37. Second malignancies after multiple myeloma: from 1960s to 2010s.
Thomas A; Mailankody S; Korde N; Kristinsson SY; Turesson I; Landgren O
Blood; 2012 Mar; 119(12):2731-7. PubMed ID: 22310913
[TBL] [Abstract][Full Text] [Related]
38. [Impacts of new agents for multiple myeloma on development of secondary myelodysplastic syndrome and acute myeloid leukemia].
Hamano A; Shingaki S; Abe Y; Miyazaki K; Sekine R; Nakagawa Y; Tsukada N; Hattori Y; Suzuki K
Rinsho Ketsueki; 2014 Apr; 55(4):428-35. PubMed ID: 24850453
[TBL] [Abstract][Full Text] [Related]
39. Data management and statistical methods used in the analysis of balanced chromosome abnormalities in therapy-related myelodysplastic syndromes and therapy-related acute leukemia: report from an international workshop.
Karrison T; Archer KJ; Espinosa R; Wen M; Huo D
Genes Chromosomes Cancer; 2002 Apr; 33(4):346-61. PubMed ID: 11921270
[No Abstract] [Full Text] [Related]
40. Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome.
Deschler B; Ihorst G; Platzbecker U; Germing U; März E; de Figuerido M; Fritzsche K; Haas P; Salih HR; Giagounidis A; Selleslag D; Labar B; de Witte T; Wijermans P; Lübbert M
Haematologica; 2013 Feb; 98(2):208-16. PubMed ID: 22875615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
